Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Since the introduction of cisplatin into the clinic, the treatment of patients with a variety of solid tumors including testicular germ cell tumors, ovarian and lung cancers, has dramatically improved. One of the main causes for therapeutic failure in these malignancies is the development of drug re...
主要な著者: | Noel, E, Perry, J, Chaplin, T, Mao, X, Cazier, J, Joel, S, Oliver, RT, Young, B, Lu, Y |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2008
|
類似資料
-
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
著者:: André van Helvoort Lengert, 等
出版事項: (2022-08-01) -
Testicular germ cell tumors
著者:: Peter Albers
出版事項: (2021-04-01) -
Immunotherapy in Testicular Germ Cell Tumors
著者:: Katarina Kalavska, 等
出版事項: (2020-09-01) -
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
著者:: Meineke Viktor, 等
出版事項: (2011-05-01) -
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
著者:: Matthias Gutekunst, 等
出版事項: (2011-01-01)